Zhejiang Medicine Co., Ltd. (SHA:600216)
China · Delayed Price · Currency is CNY 12.68
-0.03 (-0.24%)
Sep 4, 2026, 3:00 PM CST
Zhejiang Medicine Market Cap
Zhejiang Medicine has a market cap or net worth of 12.02 billion as of September 4, 2026. Its market cap has decreased by -16.85% in one year.
Market Cap
12.02B
Enterprise Value
9.37B
Revenue
8.94B
Ranking
n/a
PE Ratio
15.10
Stock Price
12.68
ChartMarket Cap Chart
Since January 2, 2001, Zhejiang Medicine's market cap has increased from 5.53B to 12.02B, an increase of 117.24%. That is a compound annual growth rate of 3.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 12.02B | -8.51% |
| Dec 31, 2025 | 13.14B | -13.86% |
| Dec 31, 2024 | 15.25B | 48.35% |
| Dec 29, 2023 | 10.28B | -8.23% |
| Dec 30, 2022 | 11.20B | -31.56% |
| Dec 31, 2021 | 16.37B | 25.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Jiuzhou Pharmaceutical | 13.16B |
| Shenzhen Hepalink Pharmaceutical Group | 13.06B |
| Nanjing King-Friend Biochemical Pharmaceutical | 12.74B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 12.12B |
| Guobang Pharma | 12.03B |
| Wedge Industrial | 12.02B |
| Shanghai Shyndec Pharmaceutical | 11.39B |
| Zhejiang CONBA Pharmaceutical | 11.14B |